STIM Jorey Chernett buys $820K worth of shares
Mar 21, 2026, 4:36 AM
0.00%
What does STIM do
Neuronetics, based in Malvern, Pennsylvania, develops the NeuroStar Advanced Therapy System, a TMS device for treating major depressive disorder. The company went public on June 28, 2018, and employs 202 people.
Jorey Chernett bought 607,400 shares of STIM on 18 March at $1.35 per share, worth a total of $820K. They now own 8,123,804 STIM shares, or a 8% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.